Tulisokibart Clinical Trials (2026): 13 Studies for Ulcerative Colitis & Colitis, Ulcerative
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
13 Tulisokibart clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 10 indications (including Ulcerative Colitis & Colitis, Ulcerative) and 5,209 total planned enrollment. 3 Phase 3 Tulisokibart trials and 7 Phase 2 are listed. 4 Tulisokibart clinical trials are actively recruiting at 133 U.S. sites across 35 states. Most recent activity: NCT06651281 (Dec 2037).
Where to Participate: All Tulisokibart Trial Sites in the U.S. (133 sites across 35 states)
Every actively recruiting Tulisokibarttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler ( Site 0036) | Chandler85225 | NCT07133633 | Map |
| AZ | AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff ( Site 0021) | Flagstaff86001 | NCT07133633 | Map |
| AZ | Arizona Arthritis & Rheumatology Associates, P.C. - Gilbert ( Site 0022) | Gilbert85297 | NCT07133633 | Map |
| AZ | AARA Arizona Arthritis & Rheumatology Associates, P.C. - Glendale ( Site 0056) | Glendale85306 | NCT07133633 | Map |
| AZ | Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117) | Sun City85351 | NCT07486960 | Map |
| AZ | GI Alliance - Sun City ( Site 5118) | Sun City85351 | NCT06430801 | Map |
| AZ | Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 0025) | Tucson85704-1140 | NCT07133633 | Map |
| AZ | Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120) | Tucson85704-1140 | NCT07486960 | Map |
| AZ | University of Arizona Clinical and Translational Sciences Research Center ( Site 5111) | Tucson85724 | NCT06430801 | Map |
| AR | University of Arkansas for Medical Sciences ( Site 5147) | Little Rock72205 | NCT06430801 | Map |
| CA | Clinnova Research ( Site 5110) | Anaheim92805 | NCT06430801 | Map |
| CA | TriWest Research Associates - Chula Vista ( Site 0013) | Chula Vista91910 | NCT07133633 | Map |
| CA | Southern California Research Center ( Site 5044) | Coronado92118 | NCT06430801 | Map |
| CA | Providence Medical Foundation ( Site 0049) | Fullerton92835 | NCT07133633 | Map |
| CA | Newport Huntington Medical Group ( Site 0005) | Huntington Beach92648 | NCT07133633 | Map |
| CA | Om Research LLC ( Site 5038) | Lancaster93534 | NCT06430801 | Map |
| CA | Cedars Sinai Medical Center ( Site 5080) | Los Angeles90048 | NCT06430801 | Map |
| CA | UCLA Clinical & Translational Research Center (CTRC) ( Site 5116) | Los Angeles90095 | NCT06430801 | Map |
| CA | University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 5128) | Orange92868 | NCT06430801 | Map |
| CA | Om Research LLC ( Site 5045) | Oxnard93030 | NCT06430801 | Map |
| CA | Medvin Clinical Research - Riverside ( Site 5115) | Riverside92508 | NCT07486960 | Map |
| CA | Clinical Applications Laboratories ( Site 5123) | San Diego92103 | NCT06430801 | Map |
| CA | Cohen Medical Centers ( Site 0034) | Thousand Oaks91360-3967 | NCT07133633 | Map |
| CA | Cohen Medical Centers ( Site 5111) | Thousand Oaks91360 | NCT07486960 | Map |
| CA | Medvin Clinical Research - Tujunga ( Site 5113) | Tujunga91042 | NCT07486960 | Map |
| CA | Inland Rheumatology Clinical Trials, Inc. ( Site 0002) | Upland91786 | NCT07133633 | Map |
| CO | University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026) | Aurora80045 | NCT06430801 | Map |
| CO | Peak Gastroenterology Associates ( Site 5023) | Colorado Springs80907 | NCT06430801 | Map |
| CO | South Denver Gastroenterology, PC ( Site 5132) | Englewood80113 | NCT06430801 | Map |
| CO | Rocky Mountain Gastroenterology ( Site 5082) | Lakewood80228 | NCT06430801 | Map |
| CT | Connecticut Clinical Research Institute ( Site 0297) | Bristol06010 | NCT06651281 | Map |
| CT | Yale University School of Medicine-Digestive Disease ( Site 5019) | New Haven06510 | NCT06430801 | Map |
| DC | Emerson Clinical Research Institute ( Site 5051) | Washington D.C.20009 | NCT06430801 | Map |
| FL | Arthritis and Rheumatic Disease Specialties ( Site 0016) | Aventura33180 | NCT07133633 | Map |
| FL | Arthritis and Rheumatic Disease Specialties ( Site 5105) | Aventura33180 | NCT07486960 | Map |
| FL | Bay Area Arthritis and Osteoporosis ( Site 0041) | Brandon33511 | NCT07133633 | Map |
| FL | GNP Research - Hollywood ( Site 0020) | Cooper City33024 | NCT07133633 | Map |
| FL | Covenant Metabolic Specialists, LLC ( Site 5150) | Fort Myers33912 | NCT06430801 | Map |
| FL | Nature Coast Clinical Research - Inverness ( Site 5042) | Inverness34452 | NCT06430801 | Map |
| FL | Sanchez Clinical Research ( Site 5144) | Miami33157 | NCT06430801 | Map |
| FL | AdventHealth Orlando ( Site 5131) | Orlando32803 | NCT06430801 | Map |
| FL | Endoscopic Research Inc ( Site 5061) | Orlando32803 | NCT06430801 | Map |
| FL | Innovation Medical Research Center ( Site 0012) | Palmetto Bay33157 | NCT07133633 | Map |
| FL | International Center for Research ( Site 5124) | Tampa33618 | NCT07486960 | Map |
| FL | USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039) | Tampa33612 | NCT06430801 | Map |
| FL | Covenant Metabolic Specialists, LLC ( Site 5143) | University Park34201 | NCT06430801 | Map |
| GA | Morehouse School Of Medicine ( Site 5071) | Atlanta30310 | NCT06430801 | Map |
| GA | Gastroenterology Associates of Central Georgia ( Site 5048) | Macon31201 | NCT06430801 | Map |
| ID | St. Luke's Clinic - Rheumatology - Boise ( Site 5109) | Boise83702-4565 | NCT07486960 | Map |
| IL | Chicago Arthritis & Regenerative Medicine ( Site 0042) | Chicago60661 | NCT07133633 | Map |
| IL | University of Chicago Medical Center ( Site 5066) | Chicago60637 | NCT06430801 | Map |
| IL | Endeavor Health ( Site 5018) | Evanston60201 | NCT06430801 | Map |
| IL | GI ALLIANCE - GURNEE ( Site 5003) | Gurnee60031 | NCT06430801 | Map |
| IL | Willow Rheumatology and Wellness, PLLC ( Site 0035) | Willowbrook60527 | NCT07133633 | Map |
| IN | Indiana University Health University Hospital ( Site 5022) | Indianapolis46202 | NCT06430801 | Map |
| IA | Iowa Digestive Disease Center ( Site 5007) | Clive50325 | NCT06430801 | Map |
| KS | University of Kansas Medical Center ( Site 5091) | Kansas City66160 | NCT06430801 | Map |
| KS | Cotton O'Neil Digestive Health Center ( Site 5033) | Topeka66606 | NCT06430801 | Map |
| KY | University of Louisville Hospital ( Site 5120) | Louisville40202 | NCT06430801 | Map |
| MD | John Hopkins University ( Site 0052) | Baltimore21224 | NCT07133633 | Map |
| MD | Walter Reed National Military Medical Center ( Site 5006) | Bethesda20889 | NCT06430801 | Map |
| MD | Arthritis and Rheumatism Associates - Rockville ( Site 0019) | Rockville20850 | NCT07133633 | Map |
| MD | Arthritis and Rheumatism Associates - Rockville ( Site 5127) | Rockville20850 | NCT07486960 | Map |
| MA | Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037) | Boston02114 | NCT06430801 | Map |
| MI | University of Michigan ( Site 5060) | Ann Arbor48109 | NCT06430801 | Map |
| MI | Clinical Research Institute of Michigan, LLC ( Site 5002) | Clinton Township48038 | NCT06430801 | Map |
| MI | St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287) | Ypsilanti48197 | NCT06651281 | Map |
| MN | Mayo Clinic in Rochester, Minnesota ( Site 5024) | Rochester55905 | NCT06430801 | Map |
| MO | Kansas City Physician Partners ( Site 0027) | Kansas City64111 | NCT07133633 | Map |
| MO | Kansas City Physician Partners ( Site 5119) | Kansas City64111 | NCT07486960 | Map |
| MO | Mid-America GI Clinical Research ( Site 5130) | Kansas City64111 | NCT06430801 | Map |
| MO | BVL Research - Kansas ( Site 0292) | Liberty64068 | NCT06651281 | Map |
| MO | BVL Research - Kansas ( Site 5099) | Liberty64068 | NCT06430801 | Map |
| MO | Velocity Clinical Research - West County Rheumatology, St. Louis ( Site 0038) | St Louis63131 | NCT07133633 | Map |
| MO | Washington University School of Medicine ( Site 5058) | St Louis63110 | NCT06430801 | Map |
| NE | Physician Research Collaboration, LLC ( Site 0057) | Lincoln68516-5497 | NCT07133633 | Map |
| NE | Physician Research Collaboration, LLC ( Site 5102) | Lincoln68516 | NCT07486960 | Map |
| NJ | HMH Justice Marie Garibaldi Medical Plaza ( Site 5072) | Hackensack07601 | NCT06430801 | Map |
| NM | Inspire Santa Fe Medical Group ( Site 0011) | Santa Fe87505 | NCT07133633 | Map |
| NY | Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017) | Great Neck11021 | NCT06430801 | Map |
| NY | New York Gastroenterology Associates ( Site 0253) | New York10075 | NCT06651281 | Map |
| NY | New York Gastroenterology Associates ( Site 5013) | New York10075 | NCT06430801 | Map |
| NY | NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078) | New York10016 | NCT06430801 | Map |
| NY | Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079) | New York10065 | NCT06430801 | Map |
| NY | Northwell Mather Hospital ( Site 5138) | Port Jefferson11777 | NCT06430801 | Map |
| NC | University of North Carolina Medical Center ( Site 5034) | Chapel Hill27514 | NCT06430801 | Map |
| NC | Atrium Health Gastroenterology MMP ( Site 5105) | Charlotte28204 | NCT06430801 | Map |
| NC | Joint and Muscle Research Institute ( Site 5108) | Charlotte28204 | NCT07486960 | Map |
| OH | Great Lakes Gastroenterology Research, LLC ( Site 5016) | Mentor44060 | NCT06430801 | Map |
| OK | Digestive Disease Specialists Inc. ( Site 5117) | Oklahoma City73114 | NCT06430801 | Map |
| OR | Oregon Health & Science University ( Site 0059) | Portland97239 | NCT07133633 | Map |
| PA | Altoona Center for Clinical Research ( Site 0004) | Duncansville16635 | NCT07133633 | Map |
| PA | Altoona Center for Clinical Research ( Site 5110) | Duncansville16635 | NCT07486960 | Map |
| PA | Penn State University Milton S. Hershey Medical Center ( Site 5102) | Hershey17033 | NCT06430801 | Map |
| PA | Hospital of the University of Pennsylvania ( Site 5134) | Philadelphia19104 | NCT07486960 | Map |
| PA | Perelman Center for Advanced Medicine ( Site 0060) | Philadelphia19104 | NCT07133633 | Map |
| PA | Thomas Jefferson University Hospital ( Site 5133) | Philadelphia19107 | NCT06430801 | Map |
| PA | Frontier Clinical Research, LLC ( Site 5098) | Uniontown15401 | NCT06430801 | Map |
| RI | University Gastroenterology - Providence - West River Street ( Site 5057) | Providence02904 | NCT06430801 | Map |
| SC | Articularis Healthcare Group dba: Low Country Rheumatology ( Site 5128) | Summerville29486 | NCT07486960 | Map |
| SD | Sanford USD Medical Center ( Site 5129) | Sioux Falls57105 | NCT06430801 | Map |
| TN | AARA Clinical Research - Murfreesboro Medical Clinic ( Site 0029) | Murfreesboro37128 | NCT07133633 | Map |
| TN | Quality Medical Research ( Site 5114) | Nashville37211 | NCT06430801 | Map |
| TN | Vanderbilt Inflammatory Bowel Disease Clinic ( Site 5049) | Nashville37204 | NCT06430801 | Map |
| TX | Rheumatology Associates ( Site 0055) | Arlington76012 | NCT07133633 | Map |
| TX | Arthritis Care of Texas ( Site 0048) | Corpus Christi78415 | NCT07133633 | Map |
| TX | Baylor University Medical Center ( Site 5031) | Dallas75246 | NCT06430801 | Map |
| TX | Epic Medical Research - Mesquite ( Site 5153) | Denton76201 | NCT06430801 | Map |
| TX | Lone Star Arthritis & Rheumatology Associates, P.C. ( Site 0028) | Fort Worth76109 | NCT07133633 | Map |
| TX | GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290) | Garland75044 | NCT06651281 | Map |
| TX | Baylor College of Medicine Medical Center ( Site 5020) | Houston77030 | NCT06430801 | Map |
| TX | Greater Houston Rheumatology ( Site 5103) | Houston77095 | NCT07486960 | Map |
| TX | Michael E. DeBakey VA Medical Center ( Site 5086) | Houston77030 | NCT06430801 | Map |
| TX | Provecta Research Network LLC ( Site 0054) | Houston77027 | NCT07133633 | Map |
| TX | AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving ( Site 0032) | Irving75039 | NCT07133633 | Map |
| TX | Caprock Gastro Research ( Site 0293) | Lubbock79424 | NCT06651281 | Map |
| TX | Caprock Gastro Research ( Site 5077) | Lubbock79424 | NCT06430801 | Map |
| TX | GI Alliance - Lubbock ( Site 0288) | Lubbock79410 | NCT06651281 | Map |
| TX | GI Alliance: Mansfield ( Site 5015) | Mansfield76063 | NCT06430801 | Map |
| TX | Epic Medical Research ( Site 0061) | Red Oak75154 | NCT07133633 | Map |
| TX | Southern Star Research Institute ( Site 0299) | San Antonio78229 | NCT06651281 | Map |
| TX | Southern Star Research Institute ( Site 5000) | San Antonio78229 | NCT06430801 | Map |
| TX | GI Alliance - Southlake ( Site 0298) | Southlake76092-9167 | NCT06651281 | Map |
| TX | GI Alliance - Southlake ( Site 5109) | Southlake76092-9167 | NCT06430801 | Map |
| TX | Advanced Rheumatology of Houston ( Site 0001) | The Woodlands77382 | NCT07133633 | Map |
| TX | DM Clinical Research - TRA ( Site 0010) | Tomball77375 | NCT07133633 | Map |
| TX | Tyler Research Institute ( Site 0294) | Tyler75701 | NCT06651281 | Map |
| TX | Tyler Research Institute ( Site 5001) | Tyler75701 | NCT06430801 | Map |
| VA | University of Virginia Health System ( Site 0291) | Charlottesville22908 | NCT06651281 | Map |
| VA | Richmond VA Medical Center ( Site 5021) | Richmond23249 | NCT06430801 | Map |
| WA | University of Washington ( Site 5115) | Seattle98195 | NCT06430801 | Map |
| WA | Washington Gastroenterology - Tacoma ( Site 0295) | Tacoma98405 | NCT06651281 | Map |
| WA | Washington Gastroenterology - Tacoma ( Site 5004) | Tacoma98405 | NCT06430801 | Map |
Tulisokibart clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | Total |
|---|---|---|---|---|
| P1 | 1 | 2 | 3 | |
| P2 | 2 | 3 | 2 | 7 |
| P3 | 2 | 1 | 3 |
Recruiting Tulisokibart clinical trials (4)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06651281 | MK-7240-011Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) | P3 | Crohn Disease | 1,380 | Nov 2024 |
| NCT07133633 | MK-7240A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) | P2 | Radiographic Axial Spondyloarthritis | 315 | Sep 2025 |
| NCT07486960 | MK-7240-015Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) | P2 | Psoriatic Arthritis | 140 | Apr 2026 |
| NCT06430801 | MK-7240A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | P3 | Crohn's Disease | 1,200 | Jun 2024 |
Tulisokibart clinical trials by indication
Healthy (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07405177 | MK-7240-009 | P1 | active not recruiting | A Study of MK-7240 in Healthy Participants (MK-7240-009) |
| NCT06575595 | PK | P1 | completed | Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010) |
Crohn Disease (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06651281 | MK-7240-011 | P3 | recruiting | Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) |
| NCT05013905 | APOLLO-CD | P2 | completed | A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) |
Ulcerative Colitis (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06052059 | MK-7240 | P3 | active not recruiting | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) |
| NCT04996797 | ARTEMIS-UC | P2 | completed | A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) |
Psoriatic Arthritis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07486960 | MK-7240-015 | P2 | recruiting | Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) |
Arthritis, Rheumatoid (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07176390 | MK-7240 | P2 | active not recruiting | A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) |
Radiographic Axial Spondyloarthritis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07133633 | MK-7240 | P2 | recruiting | A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) |
Hidradenitis Suppurativa (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06956235 | MK-7240-012 | P2 | active not recruiting | Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) |
Colitis, Ulcerative (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06829225 | MK-7240 | P1 | completed | Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) |
Crohn's Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06430801 | MK-7240 | P3 | recruiting | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) |
Diffuse Cutaneous Systemic Sclerosis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05270668 | ATHENA-SSc-ILD | P2 | active not recruiting | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) |
Tulisokibart pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| MK-7240-011 | NCT06651281 | P3 | recruiting | Crohn Disease | 1,380 | — |
| MK-7240 | NCT06430801 | P3 | recruiting | Crohn's Disease | 1,200 | — |
| MK-7240 | NCT06052059 | P3 | active not recruiting | Ulcerative Colitis | 1,020 | — |
| MK-7240 | NCT07133633 | P2 | recruiting | Radiographic Axial Spondyloarthritis | 315 | — |
| MK-7240-015 | NCT07486960 | P2 | recruiting | Psoriatic Arthritis | 140 | — |
| ATHENA-SSc-ILD | NCT05270668 | P2 | active not recruiting | Diffuse Cutaneous Systemic Sclerosis | 154 | — |
| MK-7240 | NCT07176390 | P2 | active not recruiting | Arthritis, Rheumatoid | 182 | — |
| MK-7240-012 | NCT06956235 | P2 | active not recruiting | Hidradenitis Suppurativa | 147 | — |
| ARTEMIS-UC | NCT04996797 | P2 | completed | Ulcerative Colitis | 178 | PMID 39321363 |
| APOLLO-CD | NCT05013905 | P2 | completed | Crohn Disease | 55 | PMID 40456235 |
All Tulisokibart trials (13)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06651281 | MK-7240-011 | Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) | P3 | recruiting | 1,380 | Merck Sharp & Dohme LLC | Nov 2024 |
| NCT07133633 | MK-7240 | A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) | P2 | recruiting | 315 | Merck Sharp & Dohme LLC | Sep 2025 |
| NCT07486960 | MK-7240-015 | Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) | P2 | recruiting | 140 | Merck Sharp & Dohme LLC | Apr 2026 |
| NCT06430801 | MK-7240 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | P3 | recruiting | 1,200 | Merck Sharp & Dohme LLC | Jun 2024 |
| NCT06052059 | MK-7240 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | P3 | active not recruiting | 1,020 | Merck Sharp & Dohme LLC | Oct 2023 |
| NCT05270668 | ATHENA-SSc-ILD | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) | P2 | active not recruiting | 154 | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Mar 2022 |
| NCT07176390 | MK-7240 | A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) | P2 | active not recruiting | 182 | Merck Sharp & Dohme LLC | Oct 2025 |
| NCT06956235 | MK-7240-012 | Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) | P2 | active not recruiting | 147 | Merck Sharp & Dohme LLC | Jun 2025 |
| NCT07405177 | MK-7240-009 | A Study of MK-7240 in Healthy Participants (MK-7240-009) | P1 | active not recruiting | 330 | Merck Sharp & Dohme LLC | Mar 2026 |
| NCT04996797 | ARTEMIS-UC | A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) | P2 | completed | 178 | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Jul 2021 |
| NCT05013905 | APOLLO-CD | A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) | P2 | completed | 55 | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Jul 2021 |
| NCT06575595 | PK | Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010) | P1 | completed | 60 | Merck Sharp & Dohme LLC | Sep 2024 |
| NCT06829225 | MK-7240 | Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) | P1 | completed | 48 | Merck Sharp & Dohme LLC | Jun 2024 |
Tulisokibart clinical trials: frequently asked questions
- How many Tulisokibart clinical trials are there?
- 13 Tulisokibart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 4 are marked completed.
- Are Tulisokibart clinical trials recruiting in 2026?
- Yes — 4 Tulisokibart trials are actively recruiting in 2026, with 133 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Tulisokibart being studied for?
- Tulisokibart is being studied for Ulcerative Colitis, Colitis, Ulcerative, Crohn Disease, Healthy, Diffuse Cutaneous Systemic Sclerosis and 6 more. The trials are grouped by indication on this page.
- What phase is Tulisokibart in?
- Tulisokibart clinical trials span 3 Phase 3, 7 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Tulisokibart clinical trials?
- The lead sponsor across the most Tulisokibart trials is Merck Sharp & Dohme LLC, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Tulisokibartas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: